Product Detail
Product NameMeasles virus fusion protein Antibody Biotin Conjugated
Host SpeciesRabbit
ClonalityPolyclonal
IsotypeIgG
PurificationPurified by Protein A.
ApplicationsWB IHC-P
Species ReactivityVirus
Immunogen DescKLH conjugated synthetic peptide aa 510-550 550 derived from Measles virus fusion protein
Target NameMeasles virus fusion protein
ConjugateBiotin
Excitation EmissionN A
Other NamesFusion glycoprotein F; F
Accession NoSwiss-Prot#P69353
NCBI Gene ID1489800
Uniprot
P69353
Gene ID
1489800;
Concentration1mg ml
Formulation10mM Tris Buffered Saline containing 1% BSA, 50% glycerol and 0.09% sodium azide.
Storage Store at 4C for 12 months.
Application Details
Western blotting: 1:100-1000
Immunohistochemistry1:100-500
Class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and plasma cell membrane fusion, the heptad repeat (HR) regions assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and plasma cell membranes. Directs fusion of viral and cellular membranes leading to delivery of the nucleocapsid into the cytoplasm. This fusion is pH independent and occurs directly at the outer cell membrane. The trimer of F1-F2 (F protein) probably interacts with H at the virion surface. Upon HN binding to its cellular receptor, the hydrophobic fusion peptide is unmasked and interacts with the cellular membrane, inducing the fusion between cell and virion membranes. Later in infection, F proteins expressed at the plasma membrane of infected cells could mediate fusion with adjacent cells to form syncytia, a cytopathic effect that could lead to tissue necrosis (By similarity).
If you have published an article using product C00480B, please notify us so that we can cite your literature.